Evergreen Theragnostics, Inc.
Evergreen Theragnostics was founded in 2019 to fill a need for high quality and high reliability manufacturing of centrally distributed radiopharmaceuticals, including therapeutics and antibody based radiopharmaceuticals. Our focus is on late stage clinical trials and commercial supply. Our state-of-the-art full-GMP facility, located near Newark Airport, will be opening in 2021.
Brands: Evergreen Theragnostics